Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eating | 3 | 2022 | 387 | 1.230 |
Why?
|
| Acid-Base Equilibrium | 1 | 2022 | 23 | 0.730 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 875 | 0.530 |
Why?
|
| Kidney Transplantation | 4 | 2025 | 712 | 0.510 |
Why?
|
| Liver Transplantation | 1 | 2022 | 826 | 0.440 |
Why?
|
| Hypertension | 2 | 2025 | 1276 | 0.430 |
Why?
|
| Immunosuppressive Agents | 5 | 2026 | 838 | 0.400 |
Why?
|
| Graft Rejection | 2 | 2026 | 521 | 0.360 |
Why?
|
| Osmolar Concentration | 2 | 2022 | 168 | 0.360 |
Why?
|
| Organ Transplantation | 2 | 2026 | 253 | 0.320 |
Why?
|
| Transition to Adult Care | 2 | 2023 | 103 | 0.310 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2025 | 668 | 0.270 |
Why?
|
| Urologic Surgical Procedures | 2 | 2024 | 118 | 0.240 |
Why?
|
| Adolescent | 13 | 2026 | 22569 | 0.230 |
Why?
|
| Child | 13 | 2026 | 22738 | 0.220 |
Why?
|
| Ileum | 1 | 2025 | 112 | 0.210 |
Why?
|
| Tacrolimus | 2 | 2026 | 196 | 0.210 |
Why?
|
| Metabolic Diseases | 1 | 2025 | 114 | 0.210 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2024 | 41 | 0.210 |
Why?
|
| Nephritis, Interstitial | 1 | 2024 | 11 | 0.210 |
Why?
|
| Nephrotic Syndrome | 1 | 2024 | 43 | 0.210 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2023 | 12 | 0.190 |
Why?
|
| Renal Insufficiency | 1 | 2025 | 172 | 0.190 |
Why?
|
| Urinary Bladder | 1 | 2025 | 196 | 0.190 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2025 | 484 | 0.180 |
Why?
|
| Drug Prescriptions | 1 | 2024 | 288 | 0.180 |
Why?
|
| Hemodiafiltration | 1 | 2022 | 7 | 0.180 |
Why?
|
| Propensity Score | 1 | 2024 | 377 | 0.180 |
Why?
|
| Renal Replacement Therapy | 1 | 2022 | 100 | 0.170 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 346 | 0.170 |
Why?
|
| Retrospective Studies | 9 | 2025 | 17322 | 0.170 |
Why?
|
| Recurrence | 1 | 2024 | 1139 | 0.160 |
Why?
|
| Hypotension | 1 | 2022 | 127 | 0.160 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2025 | 390 | 0.160 |
Why?
|
| Antihypertensive Agents | 1 | 2025 | 521 | 0.160 |
Why?
|
| Postoperative Complications | 2 | 2024 | 2977 | 0.150 |
Why?
|
| Humans | 18 | 2026 | 145750 | 0.140 |
Why?
|
| Blood Pressure Determination | 1 | 2019 | 145 | 0.140 |
Why?
|
| Drug Overdose | 1 | 2022 | 375 | 0.130 |
Why?
|
| Renal Dialysis | 1 | 2021 | 466 | 0.130 |
Why?
|
| Substance-Related Disorders | 1 | 2026 | 1102 | 0.120 |
Why?
|
| Prevalence | 2 | 2026 | 2874 | 0.120 |
Why?
|
| Blood Pressure | 2 | 2025 | 1782 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 1154 | 0.120 |
Why?
|
| Critical Illness | 1 | 2022 | 900 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2024 | 1372 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 599 | 0.110 |
Why?
|
| Comorbidity | 1 | 2019 | 1662 | 0.100 |
Why?
|
| Risk Factors | 3 | 2025 | 10916 | 0.090 |
Why?
|
| Graft Survival | 2 | 2025 | 519 | 0.090 |
Why?
|
| Infant | 2 | 2025 | 10089 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1582 | 0.080 |
Why?
|
| Male | 10 | 2026 | 72992 | 0.080 |
Why?
|
| Mass Screening | 1 | 2019 | 1361 | 0.080 |
Why?
|
| Obesity | 2 | 2025 | 3118 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2025 | 11793 | 0.080 |
Why?
|
| Child, Preschool | 4 | 2025 | 11866 | 0.080 |
Why?
|
| Female | 10 | 2026 | 79025 | 0.070 |
Why?
|
| United States | 2 | 2024 | 16122 | 0.060 |
Why?
|
| Spinal Dysraphism | 1 | 2025 | 110 | 0.050 |
Why?
|
| Calcineurin Inhibitors | 1 | 2024 | 69 | 0.050 |
Why?
|
| Remission Induction | 1 | 2024 | 307 | 0.050 |
Why?
|
| Proteinuria | 1 | 2023 | 104 | 0.050 |
Why?
|
| Viremia | 1 | 2024 | 160 | 0.050 |
Why?
|
| Kidney Glomerulus | 1 | 2023 | 125 | 0.050 |
Why?
|
| Toxicokinetics | 1 | 2022 | 8 | 0.050 |
Why?
|
| Valproic Acid | 1 | 2022 | 49 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2025 | 765 | 0.040 |
Why?
|
| Young Adult | 3 | 2023 | 14250 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2021 | 324 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2021 | 867 | 0.030 |
Why?
|
| Incidence | 1 | 2024 | 2933 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 2967 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2021 | 540 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1498 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3752 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 6032 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2025 | 6464 | 0.020 |
Why?
|
| Caregivers | 1 | 2021 | 1073 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 5921 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 3210 | 0.020 |
Why?
|